134 related articles for article (PubMed ID: 24190142)
1. Whole-body insulin resistance is associated with elevated serum α-fetoprotein levels in patients with chronic hepatitis C.
Kawaguchi Y; Mizuta T; Eguchi Y; Sakurai E; Motomura Y; Isoda H; Kuwashiro T; Oeda S; Iwane S; Takahashi H; Anzai K; Ozaki I
Intern Med; 2013; 52(21):2393-400. PubMed ID: 24190142
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
Abdel-Razik A; Mousa N; Abdel-Aziz M; Elhelaly R; Elzehery R; Zalata K; Elkashef W; Fouda O; Awad M; Hafez M; Eldars W
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):313-22. PubMed ID: 26618566
[TBL] [Abstract][Full Text] [Related]
3. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of alpha-fetoprotein in chronic hepatitis C.
Tai WC; Hu TH; Wang JH; Hung CH; Lu SN; Changchien CS; Lee CM
J Formos Med Assoc; 2009 Mar; 108(3):210-8. PubMed ID: 19293036
[TBL] [Abstract][Full Text] [Related]
5. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT.
Kobeisy MA; Morsy KH; Galal M; Sayed SK; Ashmawy MM; Mohammad FM
Arab J Gastroenterol; 2012 Jun; 13(2):49-53. PubMed ID: 22980591
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Chen CH; Lin ST; Kuo CL; Nien CK
Hepatogastroenterology; 2008; 55(85):1423-7. PubMed ID: 18795704
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
Hu KQ; Kyulo NL; Lim N; Elhazin B; Hillebrand DJ; Bock T
Am J Gastroenterol; 2004 May; 99(5):860-5. PubMed ID: 15128351
[TBL] [Abstract][Full Text] [Related]
9. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
10. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
Cheong JY; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Cho SW
Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C.
Mera K; Uto H; Mawatari S; Ido A; Yoshimine Y; Nosaki T; Oda K; Tabu K; Kumagai K; Tamai T; Moriuchi A; Oketani M; Shimada Y; Hidaka M; Eguchi S; Tsubouchi H
BMC Gastroenterol; 2014 Feb; 14():27. PubMed ID: 24524410
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Williams J; Livingston SE; Gretch D
J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma.
Kim CY; Kim BR; Lee SS; Jeon DH; Lee CM; Kim WS; Cho HC; Kim JJ; Lee JM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
Medicine (Baltimore); 2017 Jan; 96(2):e5844. PubMed ID: 28079817
[TBL] [Abstract][Full Text] [Related]
14. Direct acting antiviral-induced dynamic reduction of serum α fetoprotein in hepatitis C patients without hepatocellular carcinoma.
Huynh T; Hu KQ
Front Med; 2019 Dec; 13(6):658-666. PubMed ID: 31655955
[TBL] [Abstract][Full Text] [Related]
15. High Post-treatment α-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy.
Ji F; Zhou R; Wang W; Bai D; He C; Cai Z; Shen Y; Wang S; Deng H; Li Z
J Interferon Cytokine Res; 2017 Aug; 37(8):362-368. PubMed ID: 28731786
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of serum α-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antivirals.
Fouad R; Elsharkawy A; Abdel Alem S; El Kassas M; Alboraie M; Sweedy A; Afify S; Abdellatif Z; Khairy M; Esmat G
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1129-1134. PubMed ID: 30896550
[TBL] [Abstract][Full Text] [Related]
17. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
Di Bisceglie AM; Sterling RK; Chung RT; Everhart JE; Dienstag JL; Bonkovsky HL; Wright EC; Everson GT; Lindsay KL; Lok AS; Lee WM; Morgan TR; Ghany MG; Gretch DR;
J Hepatol; 2005 Sep; 43(3):434-41. PubMed ID: 16136646
[TBL] [Abstract][Full Text] [Related]
18. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
[TBL] [Abstract][Full Text] [Related]
19. Study on the relationship between insulin growth factor 1 and liver fibrosis in patients with chronic hepatitis C with type 2 diabetes mellitus.
Cao LH; Lu FM; Lu XJ; Zhu LY
J Cell Biochem; 2018 Nov; 119(11):9513-9518. PubMed ID: 30105830
[TBL] [Abstract][Full Text] [Related]
20. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response.
Tachi Y; Hirai T; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
J Gastroenterol Hepatol; 2016 May; 31(5):1001-8. PubMed ID: 27123974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
